DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5

Glanbia Announces Fifth Consecutive Year of Double Digit Growth

By square1
Share this article
Glanbia Announces Fifth Consecutive Year of Double Digit Growth

Irish global performance nutrition and ingredients group Glanbia has announced its fifth consecutive year of double digit earnings growth, with a delivery of 10.1% growth in adjusted earnings per share.

The group has also announced revenues of €3,522 million, which is up 6.9% on its previous year.

In particular, the group highlighted the success of its Global Performance Nutrition section, with revenue growth of 13.5%.

Their strategic investments in capital expenditure and acquisition totaled €222 million, signalling that the group is poised for further growth in 2015.

This follows its 2014 acquisition of Nutramino, a Scandinavian sports nutrition business, and Isopure, a US-based provider of premium branded sports nutrition products.

ADVERTISEMENT

Dairy Ireland delivered an improved performance in 2014 and was driven primarily by Consumer Products. However, its revenues declined 5.4%, reflecting a 2.2% decline in volumes and a 3.2% impact from lower pricing.

Siobhan Talbot, Group Managing Director said, “Our focus on two scale growth platforms, Global Performance Nutrition and Global Ingredients, continues to drive earnings as we leverage our market leadership and sector expertise.”

She added, “In Performance Nutrition our investment in brand growth, innovation and acquisitions drove a strong performance. The outlook for 2015 is positive and we are guilding 9% to 11% growth in adjusted earnings per share”.

© 2015 European Supermarket Magazine – your source for the latest retail news. 

Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.